‘Increased survival rates’ for bladder cancer patients given immunotherapy drug
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...
The Independent on MSN6d
‘Game changer’ immunotherapy drug could lead to increased survival rates for bladder cancer patients
The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...
Experts hail bladder cancer drug 'breakthrough'
Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...
Medscape2d
MRI Before Surgery Reduces Treatment Time for Muscle Invasive Bladder Cancer
Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...
Cure Today5d
Sasanlimab Improves Event-Free Survival for Some With Bladder Cancer
The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.
University of Sheffield6d
Survival rates for patients with operable bladder cancer significantly improved by immunotherapy before and after surgery
A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder ...
Daily Mail6d
How bladder cancer patients are more likely to survive with a 'game-changer' immunotherapy drug
For many years, survival rates for advanced bladder cancer have remained stagnant, but our findings offer hope to thousands of patients who face this devastating diagnosis. 'Patients treated with ...
The Independent6d
‘Increased survival rates’ for bladder cancer patients given immunotherapy drug
This is a major breakthrough in the treatment of bladder cancer. For many years, survival rates for advanced bladder cancer have remained stagnant, but our findings offer hope to thousands of ...